Toru Aoyama, Yukio Maezawa, Itaru Hashimoto, Kentaro Hara, Ayako Tamagawa, Keusike Kazama, Aya Kato, Haruhiko Cho, Masato Nakazono, Masakatsu Numata, Shinnosuke Kawahara, Mie Tanabe, Jyunya Morita, Takashi Oshima, Aya Saito, Norio Yukawa, Yasushi Rino
BACKGROUND/AIM: The CRP-albumin-lymphocyte (CALLY) index is a promising biomarker. We clarified the clinical impact of the CALLY index in gastric cancer patients who received curative treatment. PATIENTS AND METHODS: Consecutive patients who underwent curative resection for gastric cancer at Yokohama City University from 2005 to 2020 were selected based on medical records. The CALYY index was calculated as follows: serum ALB level (g/dl) × lymphocyte count (cells/μl)/C-reactive protein (mg/dl) ×104 Results: Two hundred fifty-nine patients were included in the present study...
April 2024: Anticancer Research